Home › Non-Hodgkin Lymphoma › Tennessee › Nashville

Pag-aaral pangklinika para sa Non-Hodgkin Lymphoma sa Nashville, TN

Isang pag-aaral para sa Non-Hodgkin Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Nashville. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Nagre-recruitPhase 1/2

Tennessee Oncology, Pllc Nashville, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05006716

Intrathecal Cytarabine and Hydrocortisone for the Early Treatment of ICANS in Patients Undergoing CAR T Therapy for Non Hodgkin Lymphoma

Nagre-recruitPhase 2

Vanderbilt University/Ingram Cancer Center, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07763210

A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

Nagre-recruitPhase 1/2

SCRI Oncology Partners ( Site 0100), Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07519772

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Nagre-recruitPhase 2

Tennessee Oncology - Nashville / Sarah Cannon Research Institute, Nashville

Edad 12 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT02693535

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Nagre-recruitPhase 1

SCRI Oncology Partners, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07101328

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

Nagre-recruitPhase 1

Sarah Cannon Research Institute, Nashville
Vanderbilt University Medical Center, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07226843

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Nagre-recruitPhase 1

Scri Oncology Partners, Nashville
Vanderbilt Medical Center, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07195916

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Nagre-recruitPhase 2

Research Site, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06526793

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

Nagre-recruitPhase 2

Tennessee Oncology, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06806033

TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas

Nagre-recruitPhase 1

SCRI Oncology Partners, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07082803

A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Nagre-recruitPhase 1/2

Research Site, Franklin · 17 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07123454

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Nagre-recruitPhase 1/2

Vanderbilt University Medical Center, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05826535

A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Nagre-recruitPhase 3

Sarah Cannon Research Institute SCRI, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT05254743

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Nagre-recruitPhase 1/2

TriStar BMT, Nashville

Edad 13 hanggang 90 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT06533579

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Nagre-recruitPhase 3

SCRI Oncology Partners, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

Nagre-recruitPhase 2

SCRI Oncology Partners, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT04792489

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Nagre-recruitObservasyonal na pag-aaral

Vanderbilt University, Nashville

Lahat ng edad · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT01351545

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

Nagre-recruitPhase 4

Tennessee Oncology, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 2, 2026 · NCT06876649

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Nagre-recruitPhase 4

Tennessee Oncology, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 2, 2026 · NCT06876662

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Nashville

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

Nagre-recruitPhase 1/2

SCRI Oncology Partners, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 3, 2025 · NCT06119685

Pag-aaral para sa Non-Hodgkin Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Nashville

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.